Researchers at Mayo Clinic say they have identified a protein that cancer cells appear to use as an immune "off switch," helping tumors weaken the body's natural defenses. The finding points to a new way scientists may be able to study how cancers avoid immune attack.
The discovery is important because one of the biggest challenges in cancer treatment is that some tumors can suppress or escape the immune response. If researchers can better understand the protein involved in that process, they may be able to design treatments that block its effect and make the immune system more effective against cancer.
The work could also have implications for immunotherapy, which aims to help the body's own defenses recognize and destroy cancer cells. A target linked to immune shutdown may offer a path to therapies that work alongside existing immunotherapy approaches or help patients who do not respond well to current options.
While the report highlights a promising advance, more research will be needed to confirm how the protein functions in different cancers and how it can be targeted safely. Even so, the study adds to growing efforts to uncover the mechanisms tumors use to survive and to turn those weak points into new treatment strategies.
